SEC FILINGS


Form S-1
ACADIA PHARMACEUTICALS INC filed this Form S-1 on 12/21/2000
Document Outline
Entire Document (1951.8 KB)
Subdocument 1 - S-1 - S-1
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - EXPLANATORY NOTE
Page 3 - SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
Page 4 - N/A
Page 5 - CHART
Page 6 - PROSPECTUS OR OF ANY SALE OF OUR COMMON STOCK. IN THIS PROSPECTUS, "ACADIA," THE
Page 7 - SUMMARY
Page 8 - OUR STRATEGY
Page 9 - THE OFFERING
Page 10 - N/A
Page 11 - RISK FACTORS
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - RISKS RELATED TO THIS OFFERING
Page 22 - N/A
Page 23 - N/A
Page 24 - NOTE REGARDING FORWARD LOOKING STATEMENTS
Page 25 - USE OF PROCEEDS
Page 26 - CAPITALIZATION
Page 27 - DILUTION
Page 28 - N/A
Page 29 - N/A
Page 30 - MANAGEMENT'S DISCUSSION AND ANALYSIS
Page 31 - RESULTS OF OPERATIONS
Page 32 - LIQUIDITY AND CAPITAL RESOURCES
Page 33 - N/A
Page 34 - RECENTLY ISSUED ACCOUNTING STANDARDS
Page 35 - BUSINESS
Page 36 - OUR SOLUTION
Page 37 - OUR DRUG DISCOVERY APPROACH
Page 38 - HOW WE USE OUR TECHNOLOGY
Page 39 - GLAUCOMA
Page 40 - CHRONIC PAIN
Page 41 - SCHIZOPHRENIA
Page 42 - ALZHEIMER'S DISEASE
Page 43 - OUR STRATEGY
Page 44 - TECHNOLOGY OVERVIEW
Page 45 - R-SAT FUNCTIONAL ASSAY SYSTEM
Page 46 - N/A
Page 47 - COLLABORATION AGREEMENTS
Page 48 - N/A
Page 49 - INTELLECTUAL PROPERTY
Page 50 - GOVERNMENT REGULATION
Page 51 - N/A
Page 52 - EMPLOYEES
Page 53 - SCIENTIFIC ADVISORY BOARD
Page 54 - CLINICAL ADVISORY BOARD
Page 55 - MANAGEMENT
Page 56 - N/A
Page 57 - BOARD COMPOSITION
Page 58 - COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION
Page 59 - EXECUTIVE COMPENSATION
Page 60 - OPTION GRANTS IN 2000
Page 61 - 2000 YEAR END OPTION VALUES
Page 62 - N/A
Page 63 - N/A
Page 64 - N/A
Page 65 - N/A
Page 66 - RELATED PARTY TRANSACTIONS
Page 67 - N/A
Page 68 - N/A
Page 69 - PRINCIPAL STOCKHOLDERS
Page 70 - N/A
Page 71 - N/A
Page 72 - DESCRIPTION OF CAPITAL STOCK
Page 73 - CHARTER AND BYLAW PROVISIONS
Page 74 - SHARES ELIGIBLE FOR FUTURE SALE
Page 75 - N/A
Page 76 - DIVIDENDS
Page 77 - GAIN ON DISPOSITION OF COMMON STOCK
Page 78 - N/A
Page 79 - UNDERWRITING
Page 80 - N/A
Page 81 - N/A
Page 82 - LEGAL MATTERS
Page 83 - INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
Page 84 - REPORT OF INDEPENDENT ACCOUNTANTS
Page 85 - CONSOLIDATED BALANCE SHEET
Page 86 - CONSOLIDATED STATEMENT OF OPERATIONS
Page 87 - N/A
Page 88 - N/A
Page 89 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Page 90 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 91 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 92 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 93 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 94 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 95 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 96 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 97 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 98 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 99 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 100 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 101 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 102 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 103 - NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)
Page 104 - N/A
Page 105 - SECURITIES AND EXCHANGE COMMISSION IS EFFECTIVE. THIS PROSPECTUS IS NOT AN OFFER
Page 106 - N/A
Page 107 - N/A
Page 108 - ITEM 13. OTHER EXPENSES OF ISSUANCE AND DISTRIBUTION
Page 109 - ITEM 16. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
Page 110 - EXHIBIT
Page 111 - ITEM 17. UNDERTAKINGS
Page 112 - SIGNATURES
Page 113 - N/A
Page 114 - EXHIBIT INDEX
Page 115 - EXHIBIT
Subdocument 2 - EX-3.1 - EX-3.1
Page 1 - N/A
Page 2 - EXHIBIT A
Page 3 - Section 242(b)(2) of the General Corporation Law of Delaware.
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - Section 4, the Corporation at its expense shall promptly compute such adjustment
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - Section C.5.c. herein, that all holders of certificates for Series D Preferred
Page 20 - Section C.5.c. herein, that all holders of certificates for Series E Preferred
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - Section 145(i) of the General Corporation Law of Delaware shall have the
Subdocument 3 - EX-3.2 - EX-3.2
Page 1 - N/A
Page 2 - EXHIBIT A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Subdocument 4 - EX-3.3 - EX-3.3
Page 1 - BY-LAWS
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - BY-LAWS
Page 5 - N/A
Page 6 - ARTICLE 2
Page 7 - N/A
Page 8 - ARTICLE 3
Page 9 - N/A
Page 10 - ARTICLE 4
Page 11 - N/A
Page 12 - ARTICLE 5
Page 13 - N/A
Page 14 - ARTICLE 6
Page 15 - AMENDMENT TO BY-LAWS
Subdocument 5 - EX-3.4 - EX-3.4
Page 1 - BYLAWS
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - SECTION 1. REGISTERED OFFICE. The registered office of the corporation
Page 6 - N/A
Page 7 - Section 13, 14 or 15(d) of the 1934 Act.
Page 8 - SECTION 7. NOTICE OF MEETINGS. Except as otherwise provided by law or
Page 9 - SECTION 8. QUORUM. At all meetings of stockholders, except where
Page 10 - SECTION 11. JOINT OWNERS OF STOCK. If shares or other securities having
Page 11 - Section 228 (c) of the DGCL. If the action which is consented to is such as
Page 12 - SECTION 16. POWERS. The powers of the corporation shall be exercised,
Page 13 - SECTION 19. RESIGNATION. Any director may resign at any time by
Page 14 - SECTION 21. QUORUM AND VOTING.
Page 15 - N/A
Page 16 - SECTION 25. ORGANIZATION. At every meeting of the directors, the
Page 17 - SECTION 28. DELEGATION OF AUTHORITY. The Board of Directors may from
Page 18 - SECTION 30. REMOVAL. Any officer may be removed from office at any
Page 19 - SECTION 34. LOST CERTIFICATES. A new certificate or certificates shall
Page 20 - SECTION 37. REGISTERED STOCKHOLDERS. The corporation shall be entitled
Page 21 - SECTION 38. EXECUTION OF OTHER SECURITIES. All bonds, debentures and
Page 22 - SECTION 41. FISCAL YEAR. The fiscal year of the corporation shall be
Page 23 - N/A
Page 24 - N/A
Page 25 - SECTION 43. NOTICES.
Page 26 - SECTION 44. AMENDMENTS. Subject to paragraph (h) of Section 42 of the
Page 27 - SECTION 45. LOANS TO OFFICERS. The corporation may lend money to, or
Page 28 - SECTION 50. EXPIRATION. The restrictions on transfer set forth in this
Subdocument 6 - EX-4.1 - EX-4.1
Page 1 - N/A
Page 2 - N/A
Subdocument 7 - EX-4.2 - EX-4.2
Page 1 - AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - AMENDED AND RESTATED STOCKHOLDERS AGREEMENT
Page 6 - ARTICLE 1
Page 7 - N/A
Page 8 - N/A
Page 9 - Section 3.3 the transferor and the transferee(s) shall be jointly and severally
Page 10 - Section 3.3 of this Agreement, such Transferring Party shall first deliver
Page 11 - N/A
Page 12 - ARTICLE 4
Page 13 - N/A
Page 14 - Section 4.3 which would have otherwise been transferred by such Participating
Page 15 - N/A
Page 16 - Section C.3.e of the Certificate, the holders of the Company's Series C
Page 17 - N/A
Page 18 - ARTICLE 7
Page 19 - N/A
Page 20 - N/A
Page 21 - ARTICLE 8
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - ARTICLE 10
Page 30 - N/A
Page 31 - N/A
Page 32 - Section 2.7(b), (c) (PROVIDED that such plan or arrangement is approved in
Page 33 - N/A
Page 34 - N/A
Page 35 - ARTICLE 11
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - BANKINVEST 7 BIOTECHNOLOGI
Page 40 - LONMODTAGERNES DYRTIDSFOND
Page 41 - THE KAUFMANN FUND
Page 42 - N/A
Page 43 - N/A
Subdocument 8 - EX-4.3 - EX-4.3
Page 1 - COMMON STOCK PURCHASE WARRANT
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - Section 2 (including provisions with respect to adjustment of the Purchase
Page 7 - Section 3 shall be delayed until such determination is made.
Page 8 - N/A
Page 9 - Section 4 hereof, issue and deliver to or upon the order of such Holder, at the
Page 10 - EXHIBIT II hereto) at the principal office of the Company.
Page 11 - N/A
Page 12 - EXHIBIT I
Page 13 - EXHIBIT II
Subdocument 9 - EX-10.1 - EX-10.1
Page 1 - INDEMNITY AGREEMENT
Page 2 - Section 41 of the Bylaws.
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - AGENT
Subdocument 10 - EX-10.2 - EX-10.2
Page 1 - N/A
Page 2 - Section 162(m) of the Code and a "non-employee director" as defined in Rule
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - - 2 -
Page 9 - - 3 -
Page 10 - - 4 -
Page 11 - - 5 -
Page 12 - - 6 -
Page 13 - N/A
Page 14 - Section 2 shall terminate at the end of the first full year following
Page 15 - N/A
Page 16 - Section 2(a) of Article Fourth of the Company's Certificate of
Page 17 - N/A
Page 18 - N/A
Page 19 - PARTICIPANT'S ACCEPTANCE
Subdocument 11 - EX-10.3 - EX-10.3
Page 1 - 2000 EQUITY INCENTIVE PLAN
Page 2 - N/A
Page 3 - N/A
Page 4 - Section 12.
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Section 162(m) of the Code and the regulations thereunder regarding the
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - NOTICE OF EXERCISE
Subdocument 12 - EX-10.4 - EX-10.4
Page 1 - 2000 NON-EMPLOYEE DIRECTORS' STOCK OPTION PLAN
Page 2 - N/A
Page 3 - Section 12.
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - NOTICE OF EXERCISE
Subdocument 13 - EX-10.5 - EX-10.5
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - Section 8(b), or is not eligible to participate in such Offering, as provided in
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - Section 423 of the Code.
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Subdocument 14 - EX-10.6 - EX-10.6
Page 1 - CORPORATEPLAN FOR RETIREMENT 100-SM-
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - TABLE OF CONTENTS
Page 6 - Section 7.04 to receive benefits under the Plan upon the death of
Page 7 - N/A
Page 8 - Section 1.03(a)(1) incurs a break in service for participation
Page 9 - Section 415(d) of the Code); (ii) received Compensation from the
Page 10 - N/A
Page 11 - Section 414(b) of the Code) or an affiliated service group (as
Page 12 - ARTICLE 3 PARTICIPATION
Page 13 - N/A
Page 14 - ARTICLE 4 CONTRIBUTIONS
Page 15 - Section 4.01(c) and Sections 4.02(d) and 4.04(d) for the Plan Year, and
Page 16 - Section 414(q)(6) of the Code). Family Members, with respect to
Page 17 - Section 4.04 and Section 404 of the Code.
Page 18 - Section 401(k) of the Code (hereafter "CODA") and a Plan subject
Page 19 - Section 401(m) of the Code for the Plan Year beginning with or
Page 20 - N/A
Page 21 - Section 1.05 to be allocated among eligible Participants, in the ratio that each
Page 22 - Section 4.10.
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - Section 415 of the Code for all Limitation Years beginning before
Page 27 - Section 401(h) or Section 419A(f)(2) of the Code after separation from
Page 28 - Section 1.14(b), until investment instructions have been received
Page 29 - N/A
Page 30 - N/A
Page 31 - Section 1.09(a), on account of hardship only. A loan will be considered
Page 32 - N/A
Page 33 - Section 8.03 apply to the Participant.
Page 34 - Section 401(a)(9) of the Code; and the portion of any
Page 35 - Section 8.03.
Page 36 - Section 8.02 providing an annuity for the life of the Participant's
Page 37 - Section 8.01(b) shall commence, if the Beneficiary is not the
Page 38 - Section 8.03(b). A spouse's consent to early distribution, if required, must
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - Section 9.05.
Page 44 - Section 10.01.
Page 45 - N/A
Page 46 - N/A
Page 47 - ARTICLE 12 MISCELLANEOUS
Page 48 - N/A
Page 49 - ARTICLE 13 PLAN ADMINISTRATION
Page 50 - ARTICLE 14 TRUST AGREEMENT
Page 51 - Section 8.02;
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - Section 2 hereof.
Subdocument 15 - EX-10.7 - EX-10.7
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Subdocument 16 - EX-10.8 - EX-10.8
Page 1 - EMPLOYMENT AGREEMENT
Page 2 - N/A
Page 3 - Section 4.1, cause for termination shall be deemed to exist upon (a) dishonesty,
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Subdocument 17 - EX-10.9 - EX-10.9
Page 1 - VIA HAND DELIVERY
Page 2 - N/A
Page 3 - N/A
Subdocument 18 - EX-10.10 - EX-10.10
Page 1 - SECURED PROMISSORY NOTE
Page 2 - N/A
Page 3 - ULI HACKSELL
Subdocument 19 - EX-10.11 - EX-10.11
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Subdocument 20 - EX-10.12 - EX-10.12
Page 1 - SEPARATION AGREEMENT AND GENERAL RELEASE
Page 2 - N/A
Page 3 - Section 5 herein, regarding the extension of the exercise period for the stock
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Subdocument 21 - EX-10.13 - EX-10.13
Page 1 - N/A
Page 2 - N/A
Page 3 - LOAN AGREEMENT
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - REPAYMENT SCHEDULE
Page 8 - PERIOD PAYMENT IN DKK PERIOD PAYMENT IN DKK
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - MINISTRY OF JUSTICE - TERMS FOR PLEDGED PROPERTY
Page 14 - N/A
Page 15 - INFORMATION ON DECLARATIONS OF VALUE FOR MORTGAGES
Page 16 - MORTGAGE DECLARATION
Page 17 - A
Page 18 - DECLARATION ON RESIDUAL PROJECT FINANCING
Page 19 - AUDITOR'S ENDORSEMENT
Page 20 - N/A
Page 21 - STANDARD TERMS FOR LOANS
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - LETTER OF SUPPORT
Subdocument 22 - EX-10.14 - EX-10.14
Page 1 - BY AND AMONG
Page 2 - TABLE OF CONTENTS
Page 3 - TABLE OF CONTENTS
Page 4 - TABLE OF CONTENTS
Page 5 - RECITALS
Page 6 - Section 4.7; and (c) with respect to a Test Target or Program Target, the
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - Section 6.2.
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - Section 2.3.
Page 17 - N/A
Page 18 - N/A
Page 19 - Section 2.5. If such Program Target is an Excluded Target, then: (i) such
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - Section 5.2 below.
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - Section 10.4, it will, except where impracticable, give reasonable advance
Page 38 - Section 5.1 of this Agreement shall survive such termination for so long as
Page 39 - N/A
Page 40 - N/A
Page 41 - N/A
Page 42 - N/A
Page 43 - Section 5.1 shall continue in full force and effect and shall be exclusive
Page 44 - N/A
Page 45 - N/A
Page 46 - EXHIBIT A
Page 47 - EXHIBIT B
Page 48 - EXHIBIT C
Page 49 - EXHIBIT D
Page 50 - EXHIBIT E
Page 51 - EXHIBIT F
Page 52 - EXHIBIT G
Page 53 - ALLERGAN AND ACADIA PHARMACEUTICALS ESTABLISH A RESEARCH COLLABORATION
Page 54 - 2-2-2
Page 55 - 3-3-3
Page 56 - 4-4-4
Subdocument 23 - EX-10.15 - EX-10.15
Page 1 - AND LICENSE AGREEMENT
Page 2 - TABLE OF CONTENTS
Page 3 - N/A
Page 4 - N/A
Page 5 - AND LICENSE AGREEMENT
Page 6 - Section 4.2.
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - Section 7.4 (b) are less than the total
Page 21 - Section 7.4 (b) and the actual total amount of the upfront fee and milestones
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - EXHIBIT A
Page 38 - PROOF OF CONCEPT IN GLAUCOMA PATIENTS
Page 39 - EXHIBIT B
Page 40 - N/A
Page 41 - N/A
Page 42 - EXHIBIT C
Page 43 - EXHIBIT D
Page 44 - MATERIALS TRANSFER AGREEMENT
Page 45 - N/A
Page 46 - N/A
Page 47 - EXHIBIT E
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Subdocument 24 - EX-10.16 - EX-10.16
Page 1 - COMPOUND DISCOVERY COLLABORATION AGREEMENT
Page 2 - N/A
Page 3 - N/A
Page 4 - Section 2.1. The Research Committee manages and directs the research and
Page 5 - Section 2.2. of this Agreement. The Steering Committee has overall authority
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - EXHIBIT A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Subdocument 25 - EX-10.17 - EX-10.17
Page 1 - EXHIBIT 10.17
Page 2 - N/A
Page 3 - N/A
Subdocument 26 - EX-10.18 - EX-10.18
Page 1 - N/A
Page 2 - N/A
Page 3 - N/A
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Page 7 - N/A
Page 8 - N/A
Page 9 - N/A
Page 10 - N/A
Page 11 - N/A
Page 12 - HARRIS FAMILY REVOCABLE TRUST
Page 13 - HARRIS FAMILY REVOCABLE TRUST
Page 14 - Section 1.5 and Section 4 of the Lease are amended by the addition of
Page 15 - N/A
Page 16 - N/A
Page 17 - N/A
Page 18 - N/A
Page 19 - N/A
Page 20 - N/A
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - N/A
Page 25 - N/A
Page 26 - N/A
Page 27 - N/A
Page 28 - N/A
Page 29 - N/A
Page 30 - N/A
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - N/A
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - HARRIS FAMILY REVOCABLE TRUST
Subdocument 27 - EX-23.1 - EX-23.1
Page 1 - CONSENT OF INDEPENDENT ACCOUNTS
Subdocument 28 - EX-27.1 - EXHIBIT 27.1
Page 1 - N/A